Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Searle uses Epimmune technologies to develop cancer therapies

March 4, 1998

Status of Oncolym updated

March 4, 1998

Select Therapeutics licenses cancer-related technology

March 3, 1998

Cell Pathways/U. of Arizona study compounds for precancerous lesions

March 3, 1998

Penclomedine metabolite shows comparable anticancer efficacy, reduced neurotoxicity

March 3, 1998

Takeda exercises option to develop therapeutic protein

March 3, 1998

New compound for mucositis in development at Alizyme

March 2, 1998

LXR and Copernicus establish cancer gene therapy collaboration

March 2, 1998

Bristol-Myers Squibb developing new paclitaxel derivatives

March 2, 1998

Improved treatment outlook for children with leukemia?

Feb. 27, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...